Increased LRP10 mRNA expression was associated with decreased patient survival in three different malignancies: hepatocellular carcinoma, lung adenocarcinoma, and pancreatic adenocarcinoma. This evidence concerns the gene LRP10 and pancreatic adenocarcinoma.